JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leyte, A.
Right arrow Articles by van Mourik, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leyte, A.
Right arrow Articles by van Mourik, J. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 266, Issue 2, 740-746, Jan, 1991

Sulfation of Tyr1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor

A Leyte, HB van Schijndel, C Niehrs, WB Huttner, MP Verbeet, K Mertens and JA van Mourik
Department of Blood Coagulation, Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Amsterdam.

The acidic region of the Factor VIII light chain was studied with regard to structural requirements for the formation of a functional von Willebrand factor (vWF)-binding site. Factor VIII mutants lacking the B domain, with additional deletions and an amino acid replacement within the sequence 1649-1689 were constructed using site-directed mutagenesis and expressed in Cos-1 cells. These mutants, which were recovered as single-chain molecules with similar specific activities, were compared in their binding to immobilized vWF. Deletion of amino acids 741-1648 or 741-1668 did not affect the binding of Factor VIII to vWF. However, a mutant with a deletion of residues 741-1689 was no longer capable of interacting with vWF. This indicates a role for residues within the sequence 1669-1689 in the formation of a vWF-binding site. When recombinant Factor VIII was expressed in the presence of chlorate, an inhibitor of protein sulfation, the resulting Factor VIII displayed strongly reduced binding to vWF. vWF binding was completely abolished when within the sequence 1669-1689 the tyrosine residue Tyr1680, which is part of a consensus tyrosine sulfation sequence, was replaced by phenylalanine. The Factor VIII sequence 1673-1689 was identified as a high affinity substrate for tyrosylprotein sulfotransferase (Km = 57 microM) in cell-free sulfation studies. It is concluded that sulfation of Tyr1680 is required for the interaction of Factor VIII with vWF. Two synthetic peptides that represent the sequence 1673-1689, but differ with respect to sulfation of Tyr1680 are shown to have vWF binding affinity that is considerably lower than the Factor VIII protein. Several models to accommodate our findings are discussed.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. Surmann-Schmitt, U. Dietz, T. Kireva, N. Adam, J. Park, A. Tagariello, P. Onnerfjord, D. Heinegard, U. Schlotzer-Schrehardt, R. Deutzmann, et al.
Ucma, a Novel Secreted Cartilage-specific Protein with Implications in Osteogenesis
J. Biol. Chem., March 14, 2008; 283(11): 7082 - 7093.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
N. Sasaki, Y. Hosoda, A. Nagata, M. Ding, J.-M. Cheng, T. Miyamoto, S. Okano, A. Asano, I. Miyoshi, and T. Agui
A Mutation in Tpst2 Encoding Tyrosylprotein Sulfotransferase Causes Dwarfism Associated with Hypothyroidism
Mol. Endocrinol., July 1, 2007; 21(7): 1713 - 1721.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. J. Hoffhines, E. Damoc, K. G. Bridges, J. A. Leary, and K. L. Moore
Detection and Purification of Tyrosine-sulfated Proteins Using a Novel Anti-sulfotyrosine Monoclonal Antibody
J. Biol. Chem., December 8, 2006; 281(49): 37877 - 37887.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Bonomi, M. Busnelli, L. Persani, G. Vassart, and S. Costagliola
Structural Differences in the Hinge Region of the Glycoprotein Hormone Receptors: Evidence from the Sulfated Tyrosine Residues
Mol. Endocrinol., December 1, 2006; 20(12): 3351 - 3363.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Onnerfjord, T. F. Heathfield, and D. Heinegard
Identification of Tyrosine Sulfation in Extracellular Leucine-rich Repeat Proteins Using Mass Spectrometry
J. Biol. Chem., January 2, 2004; 279(1): 26 - 33.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. E. Pilloff and T. S. Leyh
Allosteric and Catalytic Functions of the PPi-binding Motif in the ATP Sulfurylase-GTPase System
J. Biol. Chem., December 12, 2003; 278(50): 50435 - 50441.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. L. Moore
The Biology and Enzymology of Protein Tyrosine O-Sulfation
J. Biol. Chem., June 27, 2003; 278(27): 24243 - 24246.
[Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. A. Strott
Sulfonation and Molecular Action
Endocr. Rev., October 1, 2002; 23(5): 703 - 732.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. S. Tait, J.-F. Dong, J. A. Lopez, I. W. Dawes, and B. H. Chong
Site-directed mutagenesis of platelet glycoprotein Ibalpha demonstrating residues involved in the sulfation of tyrosines 276, 278, and 279
Blood, May 29, 2002; 99(12): 4422 - 4427.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Fong, S. M. Alam, T. Imai, B. Haribabu, and D. D. Patel
CX3CR1 Tyrosine Sulfation Enhances Fractalkine-induced Cell Adhesion
J. Biol. Chem., May 24, 2002; 277(22): 19418 - 19423.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
D J Bowen
Haemophilia A and haemophilia B: molecular insights
Mol. Pathol., April 1, 2002; 55(2): 127 - 144.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Stoilova-McPhie, B. O. Villoutreix, K. Mertens, G. Kemball-Cook, and A. Holzenburg
3-Dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography
Blood, February 15, 2002; 99(4): 1215 - 1223.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
D J Bowen
Haemophilia A and haemophilia B: molecular insights
Mol. Pathol., February 1, 2002; 55(1): 1 - 18.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. N. van den Brink, E. A. M. Turenhout, N. Bovenschen, B. G. A. D. H. Heijnen, K. Mertens, M. Peters, and J. Voorberg
Multiple VH genes are used to assemble human antibodies directed toward the A3-C1 domains of factor VIII
Blood, February 15, 2001; 97(4): 966 - 972.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. A. Preobrazhensky, S. Dragan, T. Kawano, M. A. Gavrilin, I. V. Gulina, L. Chakravarty, and P. E. Kolattukudy
Monocyte Chemotactic Protein-1 Receptor CCR2B Is a Glycoprotein That Has Tyrosine Sulfation in a Conserved Extracellular N-Terminal Region
J. Immunol., November 1, 2000; 165(9): 5295 - 5303.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Jacquemin, R. Lavend'homme, A. Benhida, B. Vanzieleghem, R. d'Oiron, J.-M. Lavergne, H. H. Brackmann, R. Schwaab, T. VandenDriessche, M. K. L. Chuah, et al.
A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor
Blood, August 1, 2000; 96(3): 958 - 965.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Jorieux, E. Fressinaud, J. Goudemand, C. Gaucher, D. Meyer, C. Mazurier, and the INSERM Network on Molecular Abnormalities in v
Conformational changes in the D' domain of von Willebrand factor induced by CYS 25 and CYS 95 mutations lead to factor VIII binding defect and multimeric impairment
Blood, May 15, 2000; 95(10): 3139 - 3145.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. J. Lenting, J. A. van Mourik, and K. Mertens
The Life Cycle of Coagulation Factor VIII in View of Its Structure and Function
Blood, December 1, 1998; 92(11): 3983 - 3996.
[Full Text] [PDF]


Home page
BloodHome page
J. F. Healey, R. T. Barrow, H. M. Tamim, I. M. Lubin, M. Shima, D. Scandella, and P. Lollar
Residues Glu2181-Val2243 Contain a Major Determinant of the Inhibitory Epitope in the C2 Domain of Human Factor VIII
Blood, November 15, 1998; 92(10): 3701 - 3709.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-B. Ouyang and K. L. Moore
Molecular Cloning and Expression of Human and Mouse Tyrosylprotein Sulfotransferase-2 and a Tyrosylprotein Sulfotransferase Homologue in Caenorhabditis elegans
J. Biol. Chem., September 18, 1998; 273(38): 24770 - 24774.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Beisswanger, D. Corbeil, C. Vannier, C. Thiele, U. Dohrmann, R. Kellner, K. Ashman, C. Niehrs, and W. B. Huttner
Existence of distinct tyrosylprotein sulfotransferase genes: Molecular characterization of tyrosylprotein sulfotransferase-2
PNAS, September 15, 1998; 95(19): 11134 - 11139.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Thorelli, R. J. Kaufman, and B. Dahlback
The C-terminal Region of the Factor V B-domain Is Crucial for the Anticoagulant Activity of Factor V
J. Biol. Chem., June 26, 1998; 273(26): 16140 - 16145.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y.-b. Ouyang, W. S. Lane, and K. L. Moore
Tyrosylprotein sulfotransferase: Purification and molecular cloning of an enzyme that catalyzes tyrosine O-sulfation, a common posttranslational modification of eukaryotic proteins
PNAS, March 17, 1998; 95(6): 2896 - 2901.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. R. Bundgaard, J. Vuust, and J. F. Rehfeld
New Consensus Features for Tyrosine O-Sulfation Determined by Mutational Analysis
J. Biol. Chem., August 29, 1997; 272(35): 21700 - 21705.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. L. Saenko and D. Scandella
The Acidic Region of the Factor VIII Light Chain and the C2 Domain Together Form the High Affinity Binding Site for von Willebrand Factor
J. Biol. Chem., July 18, 1997; 272(29): 18007 - 18014.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. L. Saenko, M. Shima, G. E. Gilbert, and D. Scandella
Slowed Release of Thrombin-cleaved Factor VIII from von Willebrand Factor by a Monoclonal and a Human Antibody Is a Novel Mechanism for Factor VIII Inhibition
J. Biol. Chem., November 1, 1996; 271(44): 27424 - 27431.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. W. Pipe and R. J. Kaufman
Factor VIII C2 Domain Missense Mutations Exhibit Defective Trafficking of Biologically Functional Proteins
J. Biol. Chem., October 11, 1996; 271(41): 25671 - 25676.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. L. Saenko and D. Scandella
A Mechanism for Inhibition of Factor VIII Binding to Phospholipid by von Willebrand Factor
J. Biol. Chem., June 9, 1995; 270(23): 13826 - 13833.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-J. S. H. Donath, P. J. Lenting, J. A. van Mourik, and K. Mertens
The Role of Cleavage of the Light Chain at Positions Arg[IMAGE] or Arg[IMAGE] in Subunit Interaction and Activation of Human Blood Coagulation Factor VIII
J. Biol. Chem., February 24, 1995; 270(8): 3648 - 3655.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. G. Sarafanov, N. M. Ananyeva, M. Shima, and E. L. Saenko
Cell Surface Heparan Sulfate Proteoglycans Participate in Factor VIII Catabolism Mediated by Low Density Lipoprotein Receptor-related Protein
J. Biol. Chem., April 6, 2001; 276(15): 11970 - 11979.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-f. Dong, P. Ye, A. J. Schade, S. Gao, G. M. Romo, N. T. Turner, L. V. McIntire, and J. A. Lopez
Tyrosine Sulfation of Glycoprotein Ibalpha . ROLE OF ELECTROSTATIC INTERACTIONS IN VON WILLEBRAND FACTOR BINDING
J. Biol. Chem., May 11, 2001; 276(20): 16690 - 16694.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1991 by the American Society for Biochemistry and Molecular Biology.